Fleroxacin in complicated urinary tract infections

Chemotherapy

Volumn 42, Issue , 1996, Pages 17-27

  Giamarellou, Helen ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Comparative studies; Enterococci; Fleroxacin oral; Intravenous; Superinfections; Urinary tract infection

Indexed keywords

ANTIINFECTIVE AGENT; AZTREONAM; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; FLEROXACIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; QUINOLONE DERIVATIVE;

CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; ENTEROCOCCUS; HEADACHE; HUMAN; INSOMNIA; INTRAVENOUS DRUG ADMINISTRATION; LABORATORY DIAGNOSIS; META ANALYSIS; MICROORGANISM; NAUSEA; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSEUDOMONAS; PYURIA; RELAPSE; STAPHYLOCOCCUS; SUPERINFECTION; URINALYSIS; URINARY TRACT INFECTION; URINE CULTURE;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CLINICAL TRIALS; FEMALE; FLEROXACIN; HUMANS; LACTAMS; MALE; URINARY TRACT INFECTIONS;

EID: 0029864296     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239488     Document Type: Article

References (29)

1. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE: Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis 1992; 15(suppl 1):216-227.
2. Schaeffer AJ: Diagnostics and categories of patients. Infection 1992:20 (suppl 3): 138-142.
3. Krieger J, Ross SO, Simonsen J: Urinary tract infections in healthy university men. Antimicrob Agents Chemother 1993:149:1046-1048.
4. Bishop MC: Urosurgical management of urinary tract infection. J Antimicrob Chemother 1994:33 (suppl A):75-91.
5. Nickel JC, Costcrton JW, McLean RJC, Olson M: Bacterial biofilms: Influence on the pathogenesis, diagnosis and treatment of urinary tract infections. J Antimicrob Chemother 1994:33(suppl A):31-42.
6. Ronald AR, Nicolle LE, Harding GKM: Standards of therapy for urinary infections in adults. Infection 1992;20(suppl 3): 164-170.
7. Giamarellou II, Soulis M, Papape-tropoulou M: Various antibiotic diffusion through slime producing Staphylococcus coagulase negative (CNS) clinical isolates (abstract 1310). 31st Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago. 1991.
8. Norrby JR: Evaluation of antibiotics for treatment of urinary tract infections. J Antimicrob Chemother 1994:33(suppl A):43-50.
9. Naber KG: Parcntcral/oral switch in complicated urinary tract infection. Clin Drug Invest 1995;9(suppl 1): 14-19.
10. Widmer AF, Wicstner A, Frei R, Zimmcrli W: Killing of non-growing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 1991;35:741-746.
11. Morck DW, Olson ME, McKay SG, Lam K, Prosser B, Cleeland R, Cos-terton JW: Therapeutic efficacy of fleroxacin for eliminating catheter-associated urinary tract infection on a rabbit model. Am J Med 1993:94 (suppl 3A):23-30.
12. Naber KG: Profile of ficroxacin. Clin Drug Invest 1995;9(suppl 1): 1-7.
13. Cox CE: An evaluation of two doses of Ro 23-6240 (fleroxacin) in the treatment of complicated or recurrent urinary tract infections (abstract 736). International Congress for Infectious Diseases. Rio de Janeiro. 1988.
14. Bernstein-Hahn L, Barclay CA, Iri-barren MA, Casellas J, Traballi CA, Farinati A: Treatment of complicated urinary tract infection with fleroxacin: A dose-finding study. Rev Infect Dis 1989; 11(suppl 5): 1359.
15. Comctta A, Kamm W, Berger JP, Glauser MP: Fleroxacin in noncomplicated urinary tract infections (UTI). 2nd International Symposium on New Quinolones. Geneva. 1988.
16. Wolfhagen MJAM, Hoepelman AIM, Verhoef J: Double-blind dose-range-finding study of fleroxacin for treatment of complicated urinary tract infections. Antimicrob Agents Chemother 1990:34:409-412.
17. Gelfand MS, Simmons BP, Craft RB, Grogan J, Amarshi N: A sequential study of intravenous and oral fleroxacin in the treatment of complicated urinary tract infection. Am J Med 1993:94(suppl 3A):126-130.
18. Barclay CA, Bcrnstcin-Hahn L, Iri-barren MA, Goldberg M: Intravenous fleroxacin followed by oral administration in the treatment of complicated UTI. 6th International Congress for Infectious Diseases. Prague, 1994.
19. DeGier RPE, Karperien A, Bouter PK, Zwinkels MGJ, Knol WRL, Verhoef J, Boon TA, Hoepelman AJM: Randomized study of combined intravenous oral fleroxacin for treatment of complicated urinary tract infections: 7 versus 14 days treatment duration. Proceedings of the 18th International Congress of Chemotherapy. Stockholm, 1994, pp 67-68.
20. Cox CE: Comparison of intravenous fleroxacin with ceftazidime for treatment of complicated urinary tract infection. Am J Med 1993;94 (suppl 3A):118-125.
21. Hooper DC, Wolfson JS: Fluoroquinolone antimicrobial agents. N Engl J Med 1991:324:384-394.
22. Nakanishi N, Yoshida S, Wakebe H, Inoue M, Mitsuhashi S: Mechanisms of clinical resistance to fluoroquinolones in Enterococcus Jaecalis. Antimicrob Agents Chemother 1991;35:1053-1059.
23. Pittman W, Moon JO, Hamrick LC, Cox CE, Clark J, Childs SJ, Pizzuti D, Fredericks J, Clair PS: Randomized double-blind trial of high- and low-dose ficroxacin versus norfloxacin for complicated urinary tract infection. Am J Med 1993;94(suppl 3A): 101-104.
24. Childs SJ: Fleroxacin versus norfloxacin for oral treatment of serious urinary tract infections. Am J Med 1993;94(suppl 3A): 105-107.
25. Pummer K: Fleroxacin versus norfloxacin in the treatment of urinary tract infections: A multiccnter double-blind. prospective randomized comparative study. Am J Med 1993: 94(suppl 3A): 108-113.
26. Naber KG, Sigl G: Fleroxacin versus ofloxacin in patients with complicated urinary tract infection: A controlled clinical study. Am J Med 1993;94(suppl 3A):114-117.
27. Palma P, Lima M, Netto N, Souza H: Comparative study of orally administered fleroxacin and norfloxacin in the treatment of complicated urinary tract infections. Proceedings of the 18th International Congress of Chemotherapy. Stockholm, 1994. p 74.
28. Leigh DA, Emmanuel FXS, Pctch VJ: Ciprofloxacin therapy in complicated urinary tract infections caused by Pseudomonas aeruginosa and other resistant bacteria. J Antimicrob Chemother 1986; 18(suppl D): 117-121.
29. Williams AH, Gruneberg RN: Ciprofloxacin and cotrimoxazole in urinary tract infection. J Antimicrob Chemother 1986; 18(suppl D):107-110.